Laurel Wealth Advisors LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Laurel Wealth Advisors LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$27,216
+10.6%
6000.0%0.01%
+20.0%
Q2 2023$24,618
+14.8%
6000.0%0.01%0.0%
Q1 2023$21,444
-5.4%
6000.0%0.01%0.0%
Q4 2022$22,662
-16.1%
6000.0%0.01%
-28.6%
Q3 2022$27,000
+22.7%
6000.0%0.01%
+40.0%
Q2 2022$22,0000.0%6000.0%0.01%0.0%
Q1 2022$22,000
+22.2%
6000.0%0.01%
+25.0%
Q4 2021$18,000
-10.0%
6000.0%0.00%0.0%
Q3 2021$20,000
-16.7%
6000.0%0.00%
-20.0%
Q2 2021$24,000
-11.1%
6000.0%0.01%
-28.6%
Q1 2021$27,000
-20.6%
6000.0%0.01%
-22.2%
Q4 2020$34,000
+21.4%
6000.0%0.01%
+12.5%
Q3 2020$28,000
-20.0%
6000.0%0.01%
-33.3%
Q2 2020$35,000
+25.0%
6000.0%0.01%
+9.1%
Q1 2020$28,000
-22.2%
6000.0%0.01%0.0%
Q4 2019$36,000
-25.0%
600
-25.0%
0.01%
-31.2%
Q3 2019$48,000
-5.9%
8000.0%0.02%
-11.1%
Q2 2019$51,000
-21.5%
8000.0%0.02%
-25.0%
Q1 2019$65,000
+51.2%
8000.0%0.02%
+41.2%
Q4 2018$43,0008000.02%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders